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Supplementary Fig. 1 Crystal structure of Ub-R:Ube2N~Ub:Ube2V2 (7BBD). a All proteins 
contained in the asymmetric unit are shown as ribbon and their 2FO-FC density is shown at 1.0 
sigma (Ub-R, Ub in red and R in blue; Ube2N~Ub, Ube2N in green and Ub in orange; Ube2V2 
in teal). b Stereo image of the active site of Ube2N. 2FO-FC density is shown at 1.0 sigma for 
selected catalytic residues (Ube2N (green): K87, D119; donor Ubiquitin (orange): G76, G75; 
acceptor Ubiquitin (red): K63). c Shown are B-factors (represented as mean ± standard error 
of the mean of N, Ca, C') for all chains in the Ub-R:Ube2N~Ub:Ube2V2 structure. Ub, 
ubiquitin; R, RING  
 
Supplementary Fig. 2 Di-ubiquitination kinetics. a Schematic cartoon of Ube2N catalyzed di-
ubiquitination kinetic experiments. b Plots of pH dependency of kinetics and c Michaelis-
Menten kinetics and corresponding western blots. Single measurements had to be excluded 
when one of the bands contained a saturated spot, making quantification impossible. These 
measurements have the pH/Ub∆GG label in gray. Data are presented as mean ± standard error 




Supplementary Fig. 3 Free ubiquitin chain formation of Ube2N mutants. a Western blot of a 
free ubiquitin chain formation assay using 1 µM TRIM21 RING. Western blot is representative 
of n = 2 independently performed experiments. b Shown is a Coomassie gel of the Ube2N 
assay stocks. This gel was run once. Uncropped blots and gels are provided in Source Data. 
Ub, ubiquitin; kDa, kilo Dalton 
  
 
Supplementary Fig. 4 Dynamic ubiquitin loop configurations. a, b, c Structural alignments of 
the donor (orange) and acceptor ubiquitin (red) found in the Ub-R:Ube2N~Ub:Ube2V2 
structure (7BBD, Ube2N in green and Ube2V2 in teal). Main differences can be seen in the β1-
β2 loop carrying L8, which is either in the loop in (donor ubiquitin, orange) or loop out 
configuration (acceptor ubiquitin, red). d Shown are B-factors (represented as mean ± standard 
error of the mean of N, Ca, C' of the Ub-R:Ube2N~Ub:Ube2V2 structure) for the donor and 
acceptor ubiquitin. Ub, ubiquitin; R, RING 
  
 
Supplementary Fig. 5 Structural Alignments. a Structural alignment between R:Ube2N~Ub 
(6S531) and Ub-R:Ube2N~Ub:Ube2V2 (7BBD, Ub-R, Ub in red and R in blue; Ube2N~Ub, 
Ube2N in green and Ub in orange; Ube2V2 in teal). b Structural alignment between Ub-
R:Ube2N~Ub:Ube2V2 and Ube2N~Ub:Ube2V2 (7BBF). Alignment was performed on 
Ube2N/Ube2V2. c Close up of the alignment shown in b. Highlighted are interactions that are 
different between the two structures and that result in different orientation of the acceptor 
ubiquitin (red). d Structural alignment between Ub-R:Ube2N~Ub:Ube2V2 and 





Supplementary Fig. 6 Crystal structure of Ube2N~Ub:UbeV2 (7BBF). a Asymmetric unit of 
Ube2N~Ub:Ube2V2 (Ube2N, green; Ub, orange; Ube2V2, teal) at 2.5 Å resolution. The three 
copies of Ube2N~Ub:Ube2V2 are related by translational non-crystallographic symmetry. b 
Overlay of the three copies of Ube2N~Ub:Ube2V2. The acceptor ubiquitin (red) was generated 
by invoking crystal symmetry. c Close up of the Ube2N:Ube2V2 binding interface. d Close up 




Supplementary Fig. 7 TRIM21-anchored ubiquitination can occur in trans. Ubiquitination 
was incubated for 20 min and performed as other ubiquitination assays but with 50 µM 
ubiquitin. All TRIM21 constructs are obligate dimers (R-R-fusions) and either tag-free or 
FLAG-tagged. Ubiquitination deficient Ub-RE12R-RE12R-FLAG can be ubiquitinated in trans in 
presence of FLAG-tag-free Ub-R-R. Western blots are representative of n = 2 independent 




Supplementary Fig. 8 Structural models for distances of different TRIM21 constructs. a 
Domain architecture of TRIM21 constructs used in biochemical and cellular assays. For 
biochemical experiments, the N-terminus of TRIM21 was mono-ubiquitinated. b Structure of 
TRIM21 PRYSPRY (blue) in complex with Fc (gray, 2IWG2). The distance shown spans from 
the N-terminal His of one to the other. c Structure of TRIM5a-B-Box-coiled-coil (blue, 
4TN33). TRIM21 and TRIM5a coiled-coils align well by sequence and show no insertions. 
Thus, TRIM5a-coiled-coil is a suitable model for the corresponding region of TRIM21. The 
distance shown spans from the N-terminus of one B-box to the other. d Structural model of 
Ub-R-R-PRYSPRY:Fc during initiation of ubiquitin chain elongation. Our Ub-
R:Ube2N~Ub:Ube2V2 (7BBD, Ub-R, Ub in red and R in blue; Ube2N~Ub, Ube2N in green 
and Ub in orange; Ube2V2 in teal) structure (as the canonical model) was superposed on the 
TRIM21-PRYSPRY:Fc structure. Lines indicate the linkers between RING and PRYSPRY. 
Ub, ubiquitin; R, RING 
  
 
Supplementary Fig. 9 Substrate binding induces catalytic RING topology. a Ubiquitin chain 
formation assay of Ub-TRIM21 constructs after 40 min. Western blot is a representative of n 
= 2 independent experiments. b Substrate (Fc) induced self-ubiquitination assay of 100 nM 
Ub-TRIM21 constructs. Full blots and additional ubiquitin blot are shown for the data shown 
in Fig. 3d. For the blot with full-length TRIM21 constructs, Ub-R-R-PS with Fc was also 
performed as a positive control (dashed line indicates cropping in Fig. 3b). c Ubiquitin western 
blot for the assay shown in Fig. 3d for Ub-R-PS and Ub-R-R-PS. d Substrate (Fc) induced self-
ubiquitination assay of 50 nM Ub-TRIM21 constructs. Reactions were incubated for 5 min. 
*(asterisk) indicates a TRIM21 degradation product that could not be removed during 
purification. Biochemical assays in b, c, d were performed in n = 3 independent experiments. 
Uncropped western blots are provided in Source Data. Ub, ubiquitin; R, RING; B, Box; CC, 
coiled-coil; PS, PRYSPRY; kDa, kilo Dalton 
  
 
Supplementary Fig. 10 Structural modelling of a cis-ubiquitinating TRIM21. In order to 
achieve ubiquitination in cis, the RING-anchored (blue) ubiquitin (red) chain must be 
sufficiently long to reach the active site on Ube2N~Ub/Ube2V2 (Ube2N in green, Ub in 
orange, Ube2V2 in teal). The chain can go around two different routes and both cases were 
modelled in this study. The ubiquitin chain was modelled using the Ub-R:Ube2N~Ub:Ube2V2 
structure (7BBD) and a structure of K63-linked Ub2 (2JF54) using PyMol. For both cases the 
acceptor ubiquitin was used as orientation for the chain direction. In Fig. 4a the priming (RING-
bound) ubiquitin was moved, whereas here it was not. The two central ubiquitin molecules (i.e. 
numbers 2 and 3) where added by modelling. A RING-anchored ubiquitin chain length of 4 




Supplementary Fig. 11 Ube2D1 cannot mediate TRIM21 ubiquitination via the catalytic 
RING topology. Fc-induced self-ubiquitination assay of 100 nM Ub-TRIM21 in the presence 
of 0.5 µM Ube2D1. Western blots represent n = 2 independently performed experiments. 
Uncropped western blots are provided in Source Data. Ub, ubiquitin; R, RING; B, Box; CC, 




Supplementary Fig. 12 Cell biological analysis of TRIM21 constructs. a Domain architecture 
of TRIM21 constructs used in cellular assays. b Transient expression of TRIM21 constructs in 
TRIM21-knock-out RPE1 cells. After electroporation, cells were either treated with MG132 or 
DMSO. Constructs with constitutive RING dimers show proteasomal turnover. Western blots 
are representative of n = 2 independent experiments. c Exemplary western blots of mEGFP-Fc 
degradation experiment shown in Fig. 5c. Western blots are representative of n = 3 or more 
independent experiments. Cells were either treated with MG132 or DMSO. d Example for flow 
cytometry. Cells were measured using forward and side scattering to assess live cells. In 
addition, green fluorescence was measured. Live cells were selected based on forward and side 
scattering and only the median GFP fluorescence of live cells was used for further analysis. 
Uncropped blots are provided in Source Data. R, RING; B, B-box; CC, coiled-coil; PS, 




Supplementary Fig. 13 Structural model of catalytic RING topology with TRIM5a. 
TRIM5 catalytic RING topology model was build based on a TRIM5 trimeric B-CCtruncated 
structure (blue, 5IEA5) and the Ub-R:Ube2N~Ub:Ube2V2 structure (7BBD, Ub-R, Ub in red 
and R in blue; Ube2N~Ub, Ube2N in green and Ub in orange; Ube2V2 in teal). The model for 
the catalytic RING topology was superposed on the B-CC structure. Linkers between the RING 
domains and B-boxes were built to connect the domains and the linker between the third RING 
and its Ub was modelled as being flexible, in line with our B-factor analysis (Supplementary 
Fig. 1c). R, RING; B, B-box; CC, coiled-coil 
  
Supplementary Table 1 Crystallographic data table. Statistics in highest resolution shell are 






Wavelength 0.9762 0.9762 
Resolution range 19.99  - 2.2 (2.279  - 2.2) 
47.74  - 2.542 (2.633  - 
2.542) 
Space group C 1 2 1 P 32 
Unit cell 99.15 108.36 75.14 90 104.99 90 
145.84 145.84 49.23 90 90 
120 
Total reflections 275272 (27761) 204185 (20653) 
Unique reflections 38727 (3856) 38540 (3845) 
Multiplicity 7.1 (7.2) 5.3 (5.4) 
Completeness (%) 99.41 (99.15) 99.89 (100.00) 
Mean I/sigma(I) 20.18 (2.23) 15.81 (1.17) 
R-merge 0.04551 (0.9457) 0.05449 (1.347) 
CC1/2 1 (0.932) 0.999 (0.497) 
Reflections used in 
refinement 38720 (3857) 38506 (3845) 
Reflections used for R-free 2004 (200) 2017 (203) 
R-work 0.2222 (0.3245) 0.2081 (0.3483) 
R-free 0.2523 (0.3285) 0.2479 (0.4045) 
CC(work) 0.854 (0.362) 0.980 (0.643) 
CC(free) 0.852 (0.279) 0.964 (0.480) 
Number of non-hydrogen 
atoms 4434 8612 
  macromolecules 4147 8573 
  ligands 2  
  solvent 285 39 
Protein residues 540 1094 
RMS(bonds) 0.002 0.015 
RMS(angles) 0.54 1.41 
Ramachandran favored (%) 96.98 96.75 
Ramachandran allowed (%) 3.02 2.79 
Ramachandran outliers (%) 0 0.46 
Rotamer outliers (%) 0.67 1.51 
Clashscore 3.38 16.05 
Average B-factor 52.09 109 
  macromolecules 52.8 109.11 
  ligands 23.61  
  solvent 42.01 85.16 
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